 |
 |
 |
 |
 |
 |
 |
In the NEWS
PRESS RELEASE . Nashville, March 7, 2008
Pathfinder Therapeutics, Inc. (PTI) is pleased to announce it has been chosen as a presenter for the SEMDA 2008 Investor Conference. This annual event will take place on Thursday, March 13th, 2008 at the Ritz Carlton Buckhead in Atlanta. This will represent an excellent opportunity to update potential investors on the advancement of PTI’s plan to commercialize its FDA-approved Surgisight Linasys™ platform for Navigated Abdominal Surgery.
The Southeastern Medical Device Association (SEMDA) Investor Conference is the ideal venue for the company to interact with investors focused on the region.
Please direct any media and investor correspondence to
Paul MacDonald at (615)783-0094 or plm@2pti.com
PRESS RELEASE . Nashville, February 13, 2008
Pathfinder Therapeutics Inc. (PTI) is providing testimony today before a congressional committee. Dr.James D Stefansic, Chief Technology Officer, will appear before the committee this morning on behalf of AdvaMed. The U.S House of Representatives Small Business Subcommittee on Investigations and Oversight has begun hearings entitled, “SBIR: Advancing Medical Breakthroughs.” Dr. Stefansic was invited to appear because of his expertise in the area of SBIR grants, having authored several grant proposals and his experience as Principal Investigator on two SBIR grants at PTI. Further updates regarding this hearing will appear once the testimony is publicly available.
2007 Press Releases
FDA 510K Approval
December 21, 2007
Linasys is awarded 510K approval
The Better World Report
September 10, 2007
http://www.enterprise.cam.ac.uk/
Pathfinder Therapeutics Press Release
April 5, 2007
American Hepato-Pancreato-Biliary Association (AHPBA), April 19-22 in Las Vegas
2006 Press Releases
Pathfinder Therapeutics Press Release
October 2, 2006
Pathfinder Therapeutics Receives $1.9 million Grant from National Cancer Institute
The Tennessean
September 25, 2006
Universities See Sharp Drop in Computer Science Majors
Nashville Business Journal
May 26, 2006
Building a Case - Pathfinder nets grant, hunts for more capital
Pathfinder Therapeutics Press Release
October 2, 2006
Pathfinder Therapeutics Presents to Investors at MedTech Insight’s “Investment In Innovation”
Archives
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Pathfinder Therapeutics, Inc. (PTI) is pleased to announce it has been chosen as a presenter for the SEMDA 2008 Investor Conference. This annual event will take place on Thursday, March 13th, 2008 . . . MORE |  |
||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
